advisorsecurities master

ENVBEnveric Biosciences, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
14826
Ticker
ENVB
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
1995-08-24
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
ENVB

Detail

Enriched 2026-08-14 20:47

Market cap
$6,244,139.35
Shares outstanding (class)
3,681,884
Shares outstanding (weighted)
4,028,477
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
6
Location
CAMBRIDGE, MA
Description

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data